If implemented, President Trump’s tariffs on Canada, China, and Mexico could upend U.S. trade. These nine charts show what’s ...
The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.
On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The Trump administration dismissed members of the Environmental Protection Agency’s (EPA) Clean Air Scientific Advisory Committee and Science Advisory Board on Tuesday, a day before the ...
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...
Kennedy Jr., Trump's pick for HHS secretary. However, it remains unclear how much could actually change if Kennedy were to be ...
NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback